|

MK-4208 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: HS-10382, Tern-701

Pipeline

Phase 1/2: 1

Top Sponsors

  • Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1

Indications

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
  • Chronic Myeloid Leukemia, Chronic Phase1
  • Chronic Myeloid Leukemia1
  • Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.